Abstract
DDX41 has recently been identified as a new autosomal dominantly inherited cancer predisposition syndrome causing increased risk of adult onset acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). We report for the first time compound heterozygote germline missense DDX41 mutations located in the DEAD-box domain, identified in two siblings by exome sequencing. Both siblings have slight dysmorphic findings, psychomotor delays and intellectual disability, and one developed blastic plasmacytoid dendritic cell neoplasm (BPDCN) at age five. RNA-sequencing of bone marrow showed DDX41 expression including both mutations. However, the allele fraction of p.Pro321Leu accounted for 96% in the RNA-sequencing indicating this mutation to be the more significant variant. Exome sequencing of the leukemic blasts identified no additional known driver mutations. There is no pattern indicating autosomal dominantly inherited cancer predisposition in the family, but the father has sarcoidosis, which has been associated with heterozygous DDX41 mutation. We propose that bi-allelic mutations in DDX41 could potentially be a new cancer predisposition syndrome associated with delayed psychomotor development.
References
Jun 18, 2002·Science·Niall G HowlettAlan D D'Andrea
Aug 30, 2002·British Journal of Haematology·Ray A CartwrightAnthony V Moorman
Sep 6, 2011·Nature Immunology·Zhiqiang ZhangYong-Jun Liu
Jun 8, 2012·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Fanny Angelot-DelettreFrancine Garnache-Ottou
Sep 11, 2012·Cancer Cell International·Tao Yan-FangPan Jian
Sep 28, 2013·Leukemia·J MenezesJ C Cigudosa
Apr 17, 2014·Journal of Medical Genetics·Katharina WimmerUNKNOWN EU-Consortium Care for CMMRD (C4CMMRD)
Aug 15, 2014·Oncotarget·Albrecht StenzingerWilko Weichert
Apr 30, 2015·Cancer Cell·Chantana PolprasertJaroslaw P Maciejewski
Dec 30, 2015·Blood·Maya LewinsohnHamish S Scott
Mar 6, 2016·Haematologica·Ruijuan LiEvan M Braunstein
Sep 15, 2016·Nature·Mary E DickinsonStephen A Murray
Nov 1, 2016·Leukemia·G BergerE Vellenga
Dec 9, 2016·Protein & Cell·Yan JiangSongying Ouyang
Feb 15, 2017·Leukemia·S KobayashiF Kimura
Mar 28, 2017·Leukemia·K SuzukiY Okuno
Mar 30, 2017·The Journal of Biological Chemistry·Dominik PetersReiner U Jänicke
May 27, 2017·International Journal of Hematology·Jesse J C CheahAnna L Brown
Aug 19, 2017·Leukemia·N ToftK Schmiegelow
Sep 1, 2017·Molecular and Clinical Oncology·Wenjun DengLiangchun Yang
Sep 15, 2017·Journal of Pediatric Hematology/oncology·Marie Jeong-Min KimDina El Demellawy
Citations
Jun 7, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kayla V HamiltonKim E Nichols
Feb 16, 2020·Genetics·Tatsuya TsukamotoDavid Greenstein
Jun 9, 2020·Frontiers in Genetics·Dustin B Miller, Stephen R Piccolo
Dec 18, 2020·PLoS Genetics·Anna ByrjalsenKarin Wadt
Apr 9, 2021·Frontiers in Genetics·Dustin B Miller, Stephen R Piccolo
Aug 6, 2021·Therapeutic Advances in Hematology·Ziqi Wan, Bing Han